Non-myeloablative hematopoietic stem cell transplantation (HSCT) is superior to disease modifying drug (DMD) treatment in highly active Relapsing Remitting Multiple Sclerosis (RRMS): interim results of the Multiple Sclerosis International Stem cell Transplant (MIST) Randomized Trial

Burt, Richard K.Northwestern Univ, Div Immunotherapy, Chicago, IL 60611 USA (author)

Non-myeloablative hematopoietic stem cell transplantation (HSCT) is superior to disease modifying drug (DMD) treatment in highly active Relapsing Remitting Multiple Sclerosis (RRMS) : interim results of the Multiple Sclerosis International Stem cell Transplant (MIST) Randomized Trial

Balabanov, RoumenNorthwestern Univ, Dept Neurol, Chicago, IL 60611 USA (author)
Snowden, John A.Sheffield Teaching Hosp, Dept Haematol, Sheffield, S Yorkshire, England (author)
Sharrack, BasilSheffield Teaching Hosp, Dept Neurol, Sheffield, S Yorkshire, England (author)
Oliveira, Maria CarolinaUniv Sao Paulo, Sao Paulo, Brazil (author)
Burman, Joachim,1974-Uppsala universitet,Neurologi(Swepub:uu)joabu293 (author)
Northwestern Univ, Div Immunotherapy, Chicago, IL 60611 USANorthwestern Univ, Dept Neurol, Chicago, IL 60611 USA (creator_code:org_t)

By the author/editor: Burt, Richard K.; Balabanov, Roume ...; Snowden, John A.; Sharrack, Basil; Oliveira, Maria ...; Burman, Joachim, ...

About the subject

MEDICAL AND HEALTH SCIENCES: MEDICAL AND HEAL ...; and Clinical Medicin ...; and Neurology

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.